Columbia University Medical Centre, USA
Dr Bapat completed his medical education in Mumbai, India and pursued further career opportunities in Canada and the UK. After completing Fellowship in Toronto General hospital in 1999, he moved to the UK and completed Cardiothoracic training in the UK and obtained FRCS.CT
h in 2005. He was appointed as a consultant at the Guys and St. Thomas’ hospital in 2007 with a special interest in aortic surgery.
He was the surgical lead for the Transcatheter Aortic Valve Implantation (TAVI) program at St. Thomas’ Hospital, which is the largest TAVI program in the UK and acts as a tertiary referral centre for complex TAVI cases. He pioneered new methods of performing TAVI (trans-aortic approach), led the original research and guidance on valve-in-valve indication and has developed smartphone Apps, which are used all over the world as a reference tool for valve-in-valve. He also leads research in advance indications of TAVR such as MAC. Dr Bapat has trained over 100 centres in TAVI all over the world and continues to participate actively in teaching and training on all aspects of TAVI.
He has been involved in early feasibility study of the Transcatheter mitral valve implantation and has performed the first-in-man implant of Edward’s FORTIS device in February 2014 and also of Medtronic’s Intrepid device prior to its acquisition. He was the PI for the global feasibility trial investigating Intrepid device.
Similarly, he has led bench and clinical application of newer tricuspid replacement and repair devices such as Navigate, Intrepid and Tricinch.
Dr Bapat has a large research and innovation program to help advance the field and has over 100 publications. He is an invited faculty for all major cardiology and cardiac surgical meeting. Dr Bapat has recently moved to Columbia University Medical Center in New York two years ago and is the lead for advance Mitral and Tricuspid therapy.